Purple Biotech (PPBT) Institutional Ownership $2.32 -0.03 (-1.28%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$2.34 +0.02 (+0.86%) As of 05/2/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Purple Biotech (NASDAQ:PPBT)CurrentInstitutional OwnershipPercentage9.64%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$229.66KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$45.18K Get PPBT Insider Trade Alerts Want to know when executives and insiders are buying or selling Purple Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PPBT Institutional Buying and Selling by Quarter Purple Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/21/2025 Kingswood Wealth Advisors LLC16,797$44K0.0%-50.0%1.262% 2/14/2025Two Sigma Securities LLC15,374$72K0.0%N/A1.156% 1/22/2025 Kingswood Wealth Advisors LLC33,594$158K0.0%N/A2.526% 8/15/2024Armistice Capital LLC1,358,000$553K0.0%-35.8%5.381% 2/13/2024Armistice Capital LLC1,882,173$1.47M0.0%N/A8.544% 2/6/2024WuXi AppTec Co. Ltd.194,139$151K0.4%N/A0.881% 1/16/2024 Kingswood Wealth Advisors LLC175,100$137K0.0%+34.0%0.795% 8/9/2023 Kingswood Wealth Advisors LLC127,950$178K0.1%N/A0.692% 2/3/2023Fisher Asset Management LLC32,200$44K0.0%N/A0.183% 1/28/2022ARK Investment Management LLC662,499$2.58M0.0%-10.0%2.554% 11/15/2021Point72 Asset Management L.P.279,294$1.28M0.0%-46.8%1.077% 10/20/2021Venture Visionary Partners LLC10,068$46K0.0%N/A0.039% 8/16/2021Point72 Asset Management L.P.525,000$2.56M0.0%N/A2.024% 8/16/2021Morgan Stanley37,988$185K0.0%-77.4%0.146% 8/11/2021Condor Capital Management21,000$102K0.0%N/A0.081% 5/18/2021Morgan Stanley167,804$693K0.0%-66.1%0.958% 5/18/2021Orbimed Advisors LLC31,418$130K0.0%-90.9%0.179% 5/13/2021Renaissance Technologies LLC219,035$905K0.0%+69.9%1.251% (Data available from 1/1/2016 forward) PPBT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PPBT shares? During the previous two years, the following institutional investors and hedge funds held shares of Purple Biotech shares: Armistice Capital LLC ($553K), WuXi AppTec Co. Ltd. ($151K), and Two Sigma Securities LLC ($72K), Kingswood Wealth Advisors LLC ($44K).Learn more on PPBT's institutional investors. What percentage of Purple Biotech stock is owned by institutional investors? 9.64% of Purple Biotech stock is owned by institutional investors. Learn more on PPBT's institutional investor holdings. Which institutional investors have been buying Purple Biotech stock? The following institutional investors have purchased Purple Biotech stock in the last 24 months: Armistice Capital LLC ($1.88M), Kingswood Wealth Advisors LLC ($205.99K), WuXi AppTec Co. Ltd. ($194.14K), and Two Sigma Securities LLC ($15.37K). How much institutional buying is happening at Purple Biotech? Institutional investors have bought a total of 2,297,680 shares in the last 24 months. This purchase volume represents approximately $229.66K in transactions. Which Purple Biotech major shareholders have been selling company stock? The following institutional investors have sold Purple Biotech stock in the last 24 months: Armistice Capital LLC ($757K), and Kingswood Wealth Advisors LLC ($16.80K). How much institutional selling is happening at Purple Biotech? Institutional investors have sold a total of 773,797 shares in the last 24 months. This volume of shares sold represents approximately $45.18K in transactions. Related Companies Moleculin Biotech Institutional Ownership Trinity Biotech Institutional Ownership Calidi Biotherapeutics Institutional Ownership Cellectar Biosciences Institutional Ownership Abpro Institutional Ownership Marker Therapeutics Institutional Ownership NeuroSense Therapeutics Institutional Ownership 23andMe Institutional Ownership MEI Pharma Institutional Ownership Synlogic Institutional Ownership This page (NASDAQ:PPBT) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Purple Biotech Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Purple Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
